Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on US Healthcare Journal.

The Next Real Estate Boom: Why Medical Office Buildings Are Outperforming in 2025
Discover why Medical Office Buildings are 2025's top real estate performers, offering resilience, strong demand, and stable returns for investors. BETTENDORF, IA, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- The commercial real estate...

American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
EXTON, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical, Inc., a pioneering medical device company focused on neurostimulation therapies for critical care patients, today announced the publication of pivotal clinical trial results in the...

New York Cosmos Relaunches as Fan-Owned, City-Driven Club
50 years after Pelé signed, the New York Cosmos™ return through fan equity, city partnerships, and a global ownership movement. NEW YORK, NY, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- The New York Cosmos, a historic name in U.S. soccer,...

Parkinson's Disease Market Research Analysis and Forecast, 2025-2035, Featuring Key Players - AbbVie, Merck & Co., GlaxoSmithKline, Novartis, and Teva Pharmaceutical - ResearchAndMarkets.com
The "Parkinson's Disease Market - A Global and Regional Analysis: Focus on Drug Class, Country, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. As Parkinson's disease is a progressive...

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower...

U.S. Court of Appeals for the Federal Circuit Affirms Prior Delaware District Court Rulings in Favor of Acadia in NUPLAZID® (pimavanserin) Composition of Matter Patent
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed a decision issued by the U.S. District Court for the District of Delaware in December 2023 confirming validity of the...

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
– The International Society for Stem Cell Research (“ISSCR”) 2025 Annual Meeting is the world’s foremost gathering of stem cell and regenerative medicine leaders – – Updated data presented at ISSCR 2025 demonstrates >50% improvement in pain and...

13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd. (“131” or the “Company”) and Launchit Solutions Inc. (“Launchit”) are pleased to announce that the Company, Launchit and 1001240330 Ontario Inc. (“Subco”), a...

U.S. Career Institute’s Online High School Program Awarded MSCHE Accreditation - DELETED
Middle States Commission on Higher Education (MSCHE) designation recognizes program excellence and adherence to education standards and regulations. FORT COLLINS, CO, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- U.S. Career Institute, a...

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral...

High Throughput Process Development Strategic Business Report 2025: Market to Reach $24.6 Billion by 2030 - Surge in Demand for Personalized Medicine Strengthens Opportunities - ResearchAndMarkets.com
The "High Throughput Process Development - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for High Throughput Process Development was valued at US$15.3 Billion in 2024 and is...

Give Dad the Gift of BBQ This Father’s Day with Dickey’s E-Gift Cards
Dallas, TX, June 13, 2025 (GLOBE NEWSWIRE) -- This Father’s Day, Dickey’s Barbecue Restaurants is offering two special promotions that allow families to celebrate dads in the best way possible – through the love of great barbecue. Whether you’re...

BTIG to Host Obesity Health Forum
BTIG announced today that the virtual BTIG Obesity Health Forum will take place on Wednesday, June 18, 2025. The forum will bring together experts, innovators, and enthusiasts across the healthcare landscape and will include thematic panel...

United States E-Bike Market Size, Share, Demand, Forecast, Report 2025-2033
The report provides an analysis of the key trends in each segment of the United States e-bike market. BROOKLYN, NY, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- Market Overview 2025-2033 The United States e-bike market size was valued at...

Liquid Bicarbonate Concentrate Recall: Nipro Removes MedicaLyte Liquid Bicarbonate Concentrate due to Contamination
This recall involves removing devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product MedicaLyte Liquid...

United States Pest Control Market Size, Growth & Trends Forecast 2025-2033
The increasing awareness among the masses about the health risks associated with pests, the growing environmental consciousness among individuals. BROOKLYN, NY, UNITED STATES, June 9, 2025 /EINPresswire.com/ -- Market Overview 2025-2033 United...

Liquid Bicarbonate Concentrate Recall: Nipro Removes MedicaLyte Liquid Bicarbonate Concentrate due to Contamination
This recall involves removing devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product MedicaLyte Liquid...

Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 Congress
Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of Anemia Patients Required a Median of...

Office of the Attorney General Preview of Pending U.S. Supreme Court Decisions
Press Releases 06/10/2025 Office of the Attorney General Preview of Pending U.S. Supreme Court Decisions All, Once again, as we near the end of the U.S. Supreme Court term, we are going to start to see decisions in some of the most consequential...

FCC Certifies EUCAST Global’s 5G Indoor Base Station, Marking Major Milestone for Secure U.S. Network Deployment
Certification Highlights EUCAST’s Role as a Trusted, Non-Chinese Alternative Supporting Rip-and-Replace Across Federal and Enterprise Networks DENVER, CO, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- EUCAST Global Inc., a leading provider...